<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00257582</url>
  </required_header>
  <id_info>
    <org_study_id>104915</org_study_id>
    <nct_id>NCT00257582</nct_id>
  </id_info>
  <brief_title>Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics</brief_title>
  <official_title>Long-term Study of Cetirizine Dry Syrup in Children Suffering From Various Type of Cutaneous Disease Accompanied With Pruritus.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the safety of long-term use of cetirizine dry syrup in children with various type
      of cutaneous disease accompanied on pruritus.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the safety</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>-severity of pruritus -total pruritus score -daily main prurutus score -Severity of eruption -Patient global Improvement rating -Body temperature -Adverse events -Cetirizine serum concentrations</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Pruritus</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cetirizine Dry Syrup</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic urticaria

          -  Eczema &amp; dermatitis group

          -  Atopic dermatitis

          -  Prurigo group: Acute prurigo, Prurigo subacuta, Chronic prurigo

          -  Pruritus cutaneous: Systemic pruritus cutaneous, Topical pruritus cutaneous

          -  Giving informed consent

          -  Children who have 2 grades or more pruritus score when assessed by the investigator or
             sub-investigator with the criteria for the diurnal or nocturnal pruritus score in the
             patient diary.

          -  Children with a pruritus severity of &quot;2.Mild&quot; or severer on the first day of the
             treatment period.

        Exclusion criteria:

          -  have a history of drug hypersensitivity

          -  are pregnant, lactating or possibly pregnant female children.

          -  have asthma that requires the treatment with corticosteroid.

          -  cannot avoid the use of external steroid classified into &quot;strong&quot;, &quot;strongest&quot; or
             &quot;very strong&quot;.

          -  have pruritus only on face and head.

          -  have inappropriate complication of dermal disorder that may influence on the
             evaluation of the study drug.

          -  are undergoing specific desensitization therapy or immunomodulation therapy or
             phototherapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
    </facility>
  </location>
  <removed_countries>
    <country>Japan</country>
  </removed_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2005</study_first_submitted>
  <study_first_submitted_qc>November 22, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2005</study_first_posted>
  <last_update_submitted>May 3, 2013</last_update_submitted>
  <last_update_submitted_qc>May 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cetirizine</keyword>
  <keyword>various type of cutaneous disease accompanied with Pruritus</keyword>
  <keyword>pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cetirizine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

